Novo Nordisk and the FDA have warned that counterfeit versions of the Danish pharma’s diabetes therapy Ozempic have been found in the US.
The falsified products – which are an attempt to mimic the look and feel of the genuine product’s pen injectors – have been reported shortly after knock-offs claiming to be off-brand or generic versions of the active ingredient semaglutide have been intercepted in Australia and Nigeria.
The US incident was reportedly bought at a retail pharmacy, appearing to have contained insulin glargine injection, and resulted in an adverse event. The Nigerian incident also involved a re-labeled insulin product.
Driving the demand for semaglutide products is not so much their use in diabetes, but rather the drug’s performance as an obesity therapy. Novo Nordisk sells a higher-dose version of the drug as Wegovy for weight loss, but supplies are limited and that has driven demand for Ozempic as an alternative.
“Patients prescribed semaglutide injectable products, FDA-approved and marketed under the brand names Ozempic and Wegovy, should be vigilant in checking their medicine to ensure they are taking an authentic, Novo Nordisk-produced version of the authorised drug and injection device,” said the pharma company in a statement.
It has provided the following tips to help spot a counterfeit:
Genuine:
- Genuine Novo Nordisk Ozempic pens do not extend or increase in length when setting the dose.
- The dose dial window only shows intended doses:
- On the pen intended to deliver 0.25/0.5 mg doses, it only shows -0-, 0.25 and 0.5 once dialled up to the intended doses
- On the pen intended to deliver a 1 mg dose, it only shows -0- and 1 mg once dialled up to the intended dose
- On the pen intended to deliver a 2 mg dose, it only shows -0- and 2 mg once dialled up to the intended dose
- Authentic Ozempic pens are currently available in the following configurations:
- 0.25/0.5 mg pen
- 1 mg pen
- 2 mg pen
- The box containing authentic Ozempic will include 4 needles which attach directly onto the pen, except the Ozempic 0.25/0.5 mg dose carton which has 6 needles.
Counterfeit:
- A counterfeit pen may be identified based on scale extending out from the pen when setting the dose.
- The label on a counterfeit pen could be of poor quality and may not adhere well to the pen.
- A counterfeit carton may have spelling mistakes on the front of the box (i.e., 1pen and 4 doses without space between ‘1’ and ‘pen’).
- A counterfeit carton may not include the tamper-resistant/perforation.
- The batch number printed on a counterfeit box may not correspond to the product strength stated on the same box and pen.
©
SecuringIndustry.com